Gastrodenol

CAS No. 57644-54-9

Gastrodenol( Bismuth subcitrate | Duosol | Gastrodenol )

Catalog No. M15103 CAS No. 57644-54-9

Gastrodenol?is a medicine available in a number of countries worldwide. It is is a mineral that is used in treating ulcers and upset stomach.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 38 In Stock
1G 45 In Stock

Biological Information

  • Product Name
    Gastrodenol
  • Note
    Research use only, not for human use.
  • Brief Description
    Gastrodenol?is a medicine available in a number of countries worldwide. It is is a mineral that is used in treating ulcers and upset stomach.
  • Description
    Gastrodenol?is a medicine available in a number of countries worldwide. It is is a mineral that is used in treating ulcers and upset stomach.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Bismuth subcitrate | Duosol | Gastrodenol
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    57644-54-9
  • Formula Weight
    704.47
  • Molecular Formula
    C12H10BiK3O14
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: > 40 mg/mL
  • SMILES
    C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+].[Bi+3]
  • Chemical Name
    Bismuth(3+) tripotassium bis(2-hydroxypropane-1,2,3-tricarboxylate)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2'-Hydroxyacetopheno...

    2’-Hydroxyacetophenone is a phenolic compound used in the synthesis of potential anti-myobacterial and anticancer agents.

  • mTRP-2 180-188

    This peptide is a TRP-tyrosinase-related protein. Its immunization results in effective induction of antitumor immunity.

  • Sisunatovir HCl

    Sisunatovir HCl is an orally available inhibitor of the RSV-F protein that has exhibited potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses in vitro.